ACOG and local diagnostic criteria for hypertensive disorders of pregnancy (HDP) in La Paz-El Alto, Bolivia: A retrospective case-control study

• Published in: Lancet Regional Health - Americas (Online) Vol. 9; p. 100194
• Main Authors: Lazo-Vega, Litzi, Toledo-Jaldin, Lilian, Badner, Abraham, Barriga-Vera, José Luis, Castro-Monrroy, Melany, Euser, Anna G., Larrea-Alvarado, Alison, Lawrence, Ian, Mérida, Carola, Mizutani, Rodrigo, Pérez, Yuri, Rocabado, Sebastian, Vargas, Manfredo, Vasan, Vikram, Julian, Colleen G., Moore, Lorna G.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2022; Elsevier
• Subjects: Eclampsia; HELLP syndrome; High altitude; Maternal mortality; Perinatal mortality; Preeclampsia; High altitude; Perinatal mortality; Maternal mortality; Preeclampsia; Eclampsia; HELLP syndrome
• ISSN: 2667-193X; 2667-193X
• DOI: 10.1016/j.lana.2022.100194

Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal death in low- to middle-income countries (LMIC). The American College of Obstetricians and Gynecologists (ACOG) updated diagnostic guidelines to align signs and symptoms with those associated with maternal death. We performed an observational study to ask whether ACOG guidelines were employed and associated with adverse outcomes in La Paz-El Alto, Bolivia, an LMIC. Medical records for all HDP discharge diagnoses (n = 734) and twice as many controls (n = 1647) were reviewed for one year at the three largest delivery sites. For the 690 cases and 1548 controls meeting inclusion criteria (singleton, 18–45 maternal age, local residence), health history, blood pressures, symptoms, lab tests, HDP diagnoses (i.e., gestational hypertension [GH]; preeclampsia [PE]; haemolysis, low platelets, high liver enzymes [HELLP] syndrome, eclampsia), and adverse outcomes were recorded. Bolivian diagnoses were compared to ACOG guidelines using accuracy analysis and associated with adverse outcomes by logistic regression. Both systems agreed with respect to eclampsia, but only 27% of all Bolivian HDP diagnoses met ACOG criteria. HDP increased adverse maternal- or perinatal-outcome risks for both systems, but ACOG guidelines enabled more pre-delivery diagnoses, graded maternal-risk assessment, and targeting of HDP terminating in maternal death. Bolivia diagnoses agreed with ACOG guidelines concerning end-stage disease (eclampsia) but not the other HDP due mainly to ACOG's recognition of a broader range of severe features. ACOG guidelines can aid in identifying pregnancies at greatest risk in LMICs, where most maternal and perinatal deaths occur. NIH TW010797, HD088590, HL138181, UL1 TR002535.